News About: Pharm. Industry


Teva-Handok acquires approval of ‘CINQAIR,’ biologic for treatment of severe asthma patients

Teva-Handok(CEO Sun-Dong Park) announced that ‘CINQAIR(generic name: reslizumab),’ a new monoclonal antibody injection for the treatment of asthma, acquired approval from the Ministry of Food and Drug Safety on the 4t...

Samsung Biologics will manufacture biologics on behalf of a European pharma

Samsung Biologics will manufacture biologics on behalf of a foreign pharmaceutical company. Samsung Biologics announced on the 6th that the foreign company was a pharmaceutical company headquartered in Europe and it ...

Green Cross Cell creates stepping stones to attract investments and enter the U.S. market with Maryland

Green Cross Cell(Deuk-Joo Lee), a cell therapy company, announced on the 6th that the company signed a ‘memorandum of understanding(MOU) for promotion of investments’ with the Maryland state of the U.S. Under the MOU...

CKD & MSD Korea adopt VR marketing program for ‘Januvia’

Chong Kun Dang(CEO Young-Joo Kim, CKD) and MSD Korea(CEO Avi BenShoshan) announced on the 6th that they implemented ‘Januvia VR Detail,’ a virtual reality(VR) program, in the field of the antidiabetic ‘Januvia’ busine...

Celgene Korea appoints Tae-Jin Ham as new CEO

Celgene Korea announced appointment of Tae-Jin Ham, a new CEO, from the 1st of September. CEO Tae-Jin Ham joined in Celgene in 2015 and continued to hold multiple positions, such as a head of the Asia region strategy...

ISU Abxis, Celltrion Bukwang record highest R&D/sales ratio in order

While KOSPI listed pharmaceutical companies had narrowly enlarged R&D expenses in the 1st half of this year compared to the same period of the last year, KOSDAQ listed pharmaceutical companies stayed the same in the i...

CJ HealthCare applies new drug approval of acid reflex treatment

The CJ HealthCare’s first new medicine, an acid reflux treatment, has taken a approval process in Korea its launch. CJ HealthCare(CEO Seok-Hee Kang) announced on the 4th that it applied product approval of ‘tegopraza...

Which are 6 pharmas exposed for rebate case related to hospital located Cheonan?

Seoul Metropolitan Police Agency’s Intellectual Crime Investigation Team announced on the 31st that it indicted 11 medical representatives from 6 pharmaceutical companies and 4 people including a director of hospital ...

Listed pharmas’ personnel expense/sales ratio at 14.7%

Listed pharmaceutical companies reportedly had a personnel expense/sales ratio approximately at 15% on average. There were only 7 companies which recorded less than 10% in the ratio: Kwang Dong Pharmaceutical, Hwail,...

Gilead-Yuhan’s co-promotion agreement for Sovaldi and Harvoni

Gilead Sciences Korea(CEO Seung-Woo Lee) and Yuhan Corporation(CEO Jung-Hee Lee) announced a co-promotion ceremony of ‘Sovaldi’ and ‘Harvoni,’ chronic hepatitis C treatments, on the 31st of August. The co-promotion a...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.